Join Us | Latest Articles | Contact

Journal Home


Editorial Board


Recent Articles


Submit to this journal


Special Issues


Current issue

Allergic Rhinitis Medications

Hideaki Shirasaki*


Department of Otolaryngology, Sapporo Medical University, Japan


*Corresponding author: Hideaki Shirasaki, Department of Otolaryngology, Sapporo Medical University, School of Medicine, Japan, E-mail: shira@sapmed.ac.jp
Int J Aller Medcations; Volume 1, Issue 1 Editorial IJAM-1-002e
Received: February 16, 2015: Accepted: February 20, 2015: Published: February 23, 2015
Citation: Shirasaki H (2015) Allergic Rhinitis Medications. Int J Aller Medcations 1:002e
Copyright: © 2015 Shirasaki H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Keywords

Cysteinyl leukotrienes, Allergic rhinitis, PAF, Thromboxane, Glucocorticoids

The nasal allergic response is a complex process involving the interaction of many mediators. The current therapeutic strategy is mainly based on drugs (antihistamines, nasal corticosteroids, etc.) and allergen immunotherapy. The most effective medication in persistent rhinitis is topical corticosteroid, which decreases all symptoms [1]. Antihistamines reduce nasal itch, sneeze and rhinorrhea [2]. Cysteinyl Leukotrienes (CysLTs) play an important role in allergic rhinitis because CysLT1 receptor antagonists relieve the symptoms of allergic rhinitis [3]. CysLT1 receptor antagonists provide a new opportunity for simultaneous management of allergic diseases of the upper and lower respiratory tract. The combination therapy is more effective and acts more rapidly than either drug used alone. Ramatroban, a thromboxane A2 receptor antagonist with clinical efficacy in allergic rhinitis, was shown to also antagonize the prostaglandin D2 receptor CRTH2 [4,5]. In addition to other inflammatory mediators, PAF have a relevant participation in allergic inflammation [6]. Rupatadine is a dual inhibitor of histamine H1 and PAF receptors, which has been shown to be an effective and generally well-tolerated treatment for allergic rhinitis and chronic urticaria. These medications for allergic rhinitis offer numerous options that are effective, and readily available to target specific nasal symptoms.


References
  1. Shirasaki H, Watanabe K, Kanaizumi E, Konno N, Sato J, et al. (2004) Expression and localization of steroid receptors in human nasal mucosa. Acta Otolaryngol 124: 958-963.

  2. Shirasaki H, Kanaizumi E, Seki N, Himi T (2012) Localization and upregulation of the nasal histamine H receptor in perennial allergic rhinitis. Mediators Inflamm 2012: 951316.

  3. Shirasaki H (2008) Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis treatment. Expert Opin Ther Targets 12: 415-423.

  4. Shirasaki H, Kikuchi M, Seki N, Kanaizumi E, Watanabe K, et al. (2007) Expression and localization of the thromboxane A2 receptor in human nasal mucosa. Prostaglandins Leukot Essent Fatty Acids 76: 315-320.

  5. Shirasaki H, Kikuchi M, Kanaizumi E, Himi T (2009) Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa. Ann Allergy Asthma Immunol 102: 110-115.

  6. Shirasaki H, Seki N, Kikuchi M, Kanaizumi E, Watanabe K, et al. (2005) Expression and localization of platelet-activating factor receptor in human nasal mucosa. Ann Allergy Asthma Immunol 95: 190-196.

International Journal of Anesthetics and Anesthesiology (ISSN: 2377-4630)
International Journal of Blood Research and Disorders   (ISSN: 2469-5696)
International Journal of Brain Disorders and Treatment (ISSN: 2469-5866)
International Journal of Cancer and Clinical Research (ISSN: 2378-3419)
International Journal of Clinical Cardiology (ISSN: 2469-5696)
Journal of Clinical Gastroenterology and Treatment (ISSN: 2469-584X)
Clinical Medical Reviews and Case Reports (ISSN: 2378-3656)
Journal of Dermatology Research and Therapy (ISSN: 2469-5750)
International Journal of Diabetes and Clinical Research (ISSN: 2377-3634)
Journal of Family Medicine and Disease Prevention (ISSN: 2469-5793)
Journal of Genetics and Genome Research (ISSN: 2378-3648)
Journal of Geriatric Medicine and Gerontology (ISSN: 2469-5858)
International Journal of Immunology and Immunotherapy (ISSN: 2378-3672)
International Journal of Medical Nano Research (ISSN: 2378-3664)
International Journal of Neurology and Neurotherapy (ISSN: 2378-3001)
International Archives of Nursing and Health Care (ISSN: 2469-5823)
International Journal of Ophthalmology and Clinical Research (ISSN: 2378-346X)
International Journal of Oral and Dental Health (ISSN: 2469-5734)
International Journal of Pathology and Clinical Research (ISSN: 2469-5807)
International Journal of Pediatric Research (ISSN: 2469-5769)
International Journal of Respiratory and Pulmonary Medicine (ISSN: 2378-3516)
Journal of Rheumatic Diseases and Treatment (ISSN: 2469-5726)
International Journal of Sports and Exercise Medicine (ISSN: 2469-5718)
International Journal of Stem Cell Research & Therapy (ISSN: 2469-570X)
International Journal of Surgery Research and Practice (ISSN: 2378-3397)
Trauma Cases and Reviews (ISSN: 2469-5777)
International Archives of Urology and Complications (ISSN: 2469-5742)
International Journal of Virology and AIDS (ISSN: 2469-567X)
More Journals

Contact Us

ClinMed International Library | Science Resource Online LLC
3511 Silverside Road, Suite 105, Wilmington, DE 19810, USA
Email: contact@clinmedlib.org
 

Feedback

Get Email alerts
 
Creative Commons License
Open Access
by ClinMed International Library is licensed under a Creative Commons Attribution 4.0 International License based on a work at https://clinmedjournals.org/.
Copyright © 2017 ClinMed International Library. All Rights Reserved.